Immunocore Holdings plc Stock Analysis & AI Score
Immunocore Holdings plc (IMCR) has an ST Score of 60.0 (B), driven by its Profitability (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $39.00 price target (+24.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Immunocore Holdings plc (IMCR) has an ST Score of 60.0 (B), driven by its Profitability (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $39.00 price target (+24.6% upside).
- Strongest
- ProfitabilityA+
- Weakest
- Financial StrengthD+
All factor grades
- ProfitabilityA+
- SentimentA+
- MomentumB+
- GrowthB
- ValuationB-
- ForecastB-
- Financial StrengthD+
- Piotroski2/9
Contact
IMCR stock: frequently asked questions
What is IMCR's ST Score?
Immunocore Holdings plc (IMCR) has an ST Score of 60.0 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IMCR a buy, hold, or sell?
Analysts rate IMCR a Buy, with a price target of $39.00 (+24.6% vs the current price). Our ST Score grades it B (60.0/100). The ST Score is a data-driven signal, not a recommendation.
What are IMCR's factor grades?
Valuation B-, Profitability A+, Financial Strength D+, Momentum B+, Growth B, Forecast B-, Sentiment A+.
What is IMCR's valuation grade?
Immunocore Holdings plc (IMCR) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IMCR's growth grade?
Immunocore Holdings plc (IMCR) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IMCR's profitability grade?
Immunocore Holdings plc (IMCR) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IMCR's financial strength grade?
Immunocore Holdings plc (IMCR) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IMCR?
The average analyst price target for Immunocore Holdings plc (IMCR) is $39.00 from 14 analysts, which is +24.6% versus the recent price of $31.29.
What is IMCR's Piotroski score?
Immunocore Holdings plc (IMCR) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.